Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 USD | +3.97% | -16.49% | +37.72% |
Evolution of the average Target Price on NextCure, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering NextCure, Inc.
HC Wainwright | |
Piper Sandler | |
Ladenburg Thalmann | |
Roth Capital Partners | |
Needham & Co. | |
BTIG | |
Truist Securities | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- NXTC Stock
- Consensus NextCure, Inc.